Analyst Ratings for Dynavax Technologies (DVAX)

DVAX Rating Summary

DVAX Price Target Summary

  |   Expand Research on DVAX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $6.17 (+143.9%)
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
1/2/2013 JPMorgan New Coverage Neutral
(N/A)
2.85
(N/A)
2.74 2.53 -7.66% Details
11/6/2012 JMP Securities New Coverage Market Outperform
(N/A)
6.00
(N/A)
4.06 2.53 -37.68% Details
1/4/2012 McNicoll Lewis & Vlak New Coverage Buy
(N/A)
8.00
(N/A)
3.28 2.53 -22.87% Details
6/3/2011 William Blair
» Updated 8/29/2012
New Coverage Outperform
(N/A)
9.00
(N/A)
2.51 2.53 0.8% Details
3/24/2011 Wedbush New Coverage Outperform
(N/A)
N/A
(N/A)
2.63 2.53 -3.8% Details
2/11/2011 Cowen New Coverage Outperform
(N/A)
N/A
(N/A)
3.05 2.53 -17.05% Details
11/8/2010 Jefferies
» Updated 3/4/2013
New Coverage Buy
(N/A)
5.00
(N/A)
2.06 2.53 22.82% Details
Like DVAX Ratings? Also take a look at GSK, MRVL, NUS, PG

DVAX Ratings News